StockNews.com Initiates Coverage on FibroGen (NASDAQ:FGEN)
StockNews.com started coverage on shares of FibroGen (NASDAQ:FGEN – Free Report) in a research note published on Friday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, William Blair reissued a market perform rating on shares of FibroGen in a report on Monday, June 3rd. Get Our Latest Research Report on FibroGen […]
30 Sep 07:06 · The Markets Daily